Staats HF - Search Results

1

Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.

Horowitz NS, Staats HF, Palker TJ. Horowitz NS, et al. Among authors: staats hf. Immunopharmacology. 1995 Nov;31(1):31-41. doi: 10.1016/0162-3109(95)00031-2. Immunopharmacology. 1995. PMID: 8655289

2

Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).

Staats HF, Nichols WG, Palker TJ. Staats HF, et al. J Immunol. 1996 Jul 1;157(1):462-72. J Immunol. 1996. PMID: 8683152

3

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.

Palker TJ, Muir AJ, Spragion DE, Staats HF, Langlois A, Montefiori DC. Palker TJ, et al. Among authors: staats hf. Virology. 1996 Oct 15;224(2):415-26. doi: 10.1006/viro.1996.0548. Virology. 1996. PMID: 8874502 Free article.

4

Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.

Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. Porgador A, et al. Among authors: staats hf. J Immunol. 1997 Jan 15;158(2):834-41. J Immunol. 1997. PMID: 8993001

5

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses.

Staats HF, Montgomery SP, Palker TJ. Staats HF, et al. AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):945-52. doi: 10.1089/aid.1997.13.945. AIDS Res Hum Retroviruses. 1997. PMID: 9223410

6

IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens.

Staats HF, Ennis FA Jr. Staats HF, et al. J Immunol. 1999 May 15;162(10):6141-7. J Immunol. 1999. PMID: 10229857

7

Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization.

Staats HF, Bradney CP, Gwinn WM, Jackson SS, Sempowski GD, Liao HX, Letvin NL, Haynes BF. Staats HF, et al. J Immunol. 2001 Nov 1;167(9):5386-94. doi: 10.4049/jimmunol.167.9.5386. J Immunol. 2001. PMID: 11673557

8

Oral immunogenicity of the plant proteinase bromelain.

Hale LP, Fitzhugh DJ, Staats HF. Hale LP, et al. Among authors: staats hf. Int Immunopharmacol. 2006 Dec 20;6(13-14):2038-46. doi: 10.1016/j.intimp.2006.08.007. Epub 2006 Sep 5. Int Immunopharmacol. 2006. PMID: 17161360

9

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

Gwinn WM, Johnson BT, Kirwan SM, Sobel AE, Abraham SN, Gunn MD, Staats HF. Gwinn WM, et al. Among authors: staats hf. Vaccine. 2013 Mar 1;31(11):1480-9. doi: 10.1016/j.vaccine.2013.01.012. Epub 2013 Jan 23. Vaccine. 2013. PMID: 23352329 Free PMC article.

10

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee JR. Marinaro M, et al. Among authors: staats hf. J Immunol. 1995 Nov 15;155(10):4621-9. J Immunol. 1995. PMID: 7594461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters